Profound Medical Corp.
Profound Medical Corp. (PROF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PROF · as of Jun 8, 2026
Key Statistics
Explore Profound Medical Corp. Data
prof stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The PROF analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +82.65% upside from the current price of $6.57.
Competitors & Peers
prof competitorsPROF
ARMP
AVR
CATX
LNSR
MXCTStock Performance
Full HistoryAbout Profound Medical Corp.
Profound Medical Corp. through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative p…
what is profound medical corp. · prof stock overview · profound medical corp. company profile · who is profound medical corp. ceo · prof NASDAQ · profound medical corp. headquarters · profound medical corp. business segments
About Stock Overview & Key Data
Profound Medical Corp. (PROF) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 29, 2019. As of the latest trading session, PROF stock price is $6.57, with a market capitalization of $198.8M. The stock has returned +14.26% over the past 12 months and -16.52% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Profound Medical Corp. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Profound Medical Corp. reported revenue of $16.4M and net income of -$43.3M. For detailed data — including Profound Medical Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Profound Medical Corp. (PROF) stock price is $6.57. The stock is traded on NASDAQ under the ticker symbol PROF. The 52-week range is $3.76 – $8.95.